BioTelemetry, Inc. Overview
Pro stress-test →BioTelemetry is a mobile and wireless medical technology company specializing in remote cardiac monitoring and clinical research solutions. Acquired by Philips in 2021, it operates as a subsidiary within Philips' broader healthcare technology portfolio, leveraging its expertise in connected health platforms and cardio diagnostics.
Strategic Profile
Pro stress-test →BioTelemetry maintains market leadership in remote cardio diagnostics through proprietary technology and strong customer relationships. As part of Philips, it benefits from integrated distribution networks and access to broader healthcare solutions, positioning it to expand bundled remote monitoring and cardiac care offerings across enterprise healthcare systems.
Competitive Landscape
Pro stress-test →BioTelemetry competes in the remote cardiac monitoring and digital health market alongside device manufacturers and health IT companies offering connected monitoring solutions. Key competitors include companies providing similar remote patient monitoring platforms and cardiac diagnostic services integrated with broader healthcare IT ecosystems.
Industry Context
BioTelemetry, Inc. operates in Biotechnology Research / Connected Health.
Key facts
Founded: 1999 · Headquarters: Malvern, PA, US · Employees: 614 · Revenue: $179M